Perrigo Company plc – LSE:0Y5E.L
Perrigo Company stock price today
Perrigo Company stock price monthly change
Perrigo Company stock price quarterly change
Perrigo Company stock price yearly change
Perrigo Company key metrics
Market Cap | 3.47B |
Enterprise value | 6.78B |
P/E | -22.71 |
EV/Sales | 1.54 |
EV/EBITDA | 24.63 |
Price/Sales | 0.79 |
Price/Book | 0.77 |
PEG ratio | -2.44 |
EPS | -0.03 |
Revenue | 4.55B |
EBITDA | 633.7M |
Income | -5.60M |
Revenue Q/Q | -8.41% |
Revenue Y/Y | -0.06% |
Profit margin | -3.53% |
Oper. margin | 3.49% |
Gross margin | 36.08% |
EBIT margin | 3.49% |
EBITDA margin | 13.91% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePerrigo Company stock price history
Perrigo Company stock forecast
Perrigo Company financial statements
| Jul 2023 | 1.19B | 8.4M | 0.7% |
|---|---|---|---|
| Sep 2023 | 1.12B | 14.2M | 1.26% |
| Dec 2023 | 1.15B | -32.3M | -2.79% |
| Mar 2024 | 1.08B | 4.09M | 0.38% |
| Sep 2025 | 1.21B | 114.20M | 9.4% |
|---|---|---|---|
| Dec 2025 | 1.27B | 125.21M | 9.86% |
| Dec 2025 | 1.24B | 120.59M | 9.67% |
| Mar 2026 | 1.19B | 115.58M | 9.66% |
Analysts Price target
Financials & Ratios estimates
Paying a dividend while loss making.
| Payout ratio | -97.16% |
|---|
| 2019 | 1.6% |
|---|---|
| 2020 | 2.04% |
| 2021 | 2.49% |
| 2022 | 3.11% |
| 2023 | 3.44% |
| Jul 2023 | 10964700000 | 6.11B | 55.78% |
|---|---|---|---|
| Sep 2023 | 10758300000 | 6.02B | 55.96% |
| Dec 2023 | 10809100000 | 6.04B | 55.89% |
| Mar 2024 | 10640300000 | 5.95B | 55.95% |
| Jul 2023 | 52.9M | -4.4M | -48.6M |
|---|---|---|---|
| Sep 2023 | 124.5M | -30.7M | -43.3M |
| Dec 2023 | 208.7M | -22.8M | -44.6M |
| Mar 2024 | -1.4M | -23.5M | -60.4M |
Perrigo Company alternative data
| Aug 2023 | 8,900 |
|---|---|
| Sep 2023 | 8,900 |
| Oct 2023 | 8,900 |
| Nov 2023 | 8,900 |
| Dec 2023 | 8,900 |
| Jan 2024 | 8,900 |
| Feb 2024 | 8,900 |
| Apr 2024 | 9,140 |
| May 2024 | 9,140 |
| Jun 2024 | 9,140 |
| Jul 2024 | 9,140 |
Perrigo Company other data
| Insider | Compensation |
|---|---|
| Mr. Murray S. Kessler (1960) Chief Executive Officer, Pres & Director | $3,060,000 |
Mr. Raymond P. Silcock (1951) Chief Financial Officer, Principal Accounting Officer & Executive Vice President | $1,480,000 |
| Mr. Svend Andersen (1962) Executive Vice President & Pres of Consumer Healthcare International | $1,080,000 |
| Mr. James E. Dillard III (1964) Executive Vice President & Chief Scientific Officer | $1,010,000 |
Mr. Ronald C. Janish Chief Transformation Officer and Executive Vice President of Global Operations & Supply Chain | |
Ms. Mary Reilly-Brest Director of Global Organizational and Human Resource Devel. | |
| Mr. Todd W. Kingma Executive Vice President, Gen. Counsel & Sec. | |
Mr. Shannon Hukill Senior Director of Technical Operations | |
| Mr. Bradley Joseph Vice President of Global Investor Relations & Corporation Communications | |
Mr. Thomas M. Farrington Chief Information Officer & Executive Vice President |
-
What's the price of Perrigo Company stock today?
One share of Perrigo Company stock can currently be purchased for approximately $75.69.
-
When is Perrigo Company's next earnings date?
Unfortunately, Perrigo Company's (0Y5E.L) next earnings date is currently unknown.
-
Does Perrigo Company pay dividends?
Yes, Perrigo Company pays dividends and its trailing 12-month yield is 4.31% with -97% payout ratio.It means that the company is paying a dividend while loss making. The last Perrigo Company stock dividend of $0.23 was paid on 15 Sep 2020.
-
How much money does Perrigo Company make?
Perrigo Company has a market capitalization of 3.47B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.58% to 4.66B US dollars.
-
What is Perrigo Company's stock symbol?
Perrigo Company plc is traded on the LSE under the ticker symbol "0Y5E.L".
-
What is Perrigo Company's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Perrigo Company?
Shares of Perrigo Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Perrigo Company's key executives?
Perrigo Company's management team includes the following people:
- Mr. Murray S. Kessler Chief Executive Officer, Pres & Director(age: 65, pay: $3,060,000)
- Mr. Raymond P. Silcock Chief Financial Officer, Principal Accounting Officer & Executive Vice President(age: 74, pay: $1,480,000)
- Mr. Svend Andersen Executive Vice President & Pres of Consumer Healthcare International(age: 63, pay: $1,080,000)
- Mr. James E. Dillard III Executive Vice President & Chief Scientific Officer(age: 61, pay: $1,010,000)
- Mr. Ronald C. Janish Chief Transformation Officer and Executive Vice President of Global Operations & Supply Chain
- Ms. Mary Reilly-Brest Director of Global Organizational and Human Resource Devel.
- Mr. Todd W. Kingma Executive Vice President, Gen. Counsel & Sec.
- Mr. Shannon Hukill Senior Director of Technical Operations
- Mr. Bradley Joseph Vice President of Global Investor Relations & Corporation Communications
- Mr. Thomas M. Farrington Chief Information Officer & Executive Vice President
-
How many employees does Perrigo Company have?
As Jul 2024, Perrigo Company employs 9,140 workers.
-
When Perrigo Company went public?
Perrigo Company plc is publicly traded company for more then 7 years since IPO on 22 Jan 2018.
-
What is Perrigo Company's official website?
The official website for Perrigo Company is perrigo.com.
-
How can i contact Perrigo Company?
Perrigo Company can be reached via phone at +353 1 709 4000.
Perrigo Company company profile:
Perrigo Company plc
perrigo.comLSE
9,140
Medical - Pharmaceuticals
Healthcare
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Dublin, 2
:
ISIN: IE00BGH1M568
:
